相符 发表于 2025-3-23 11:20:54

http://reply.papertrans.cn/1/94/9339/9339-11.png

NATAL 发表于 2025-3-23 17:17:40

http://reply.papertrans.cn/1/94/9339/9339-12.png

兵团 发表于 2025-3-23 18:13:16

http://reply.papertrans.cn/1/94/9339/9339-13.png

健忘症 发表于 2025-3-24 00:16:44

Submitted on: 23 November 2002.
Revised on: 20 March 2003.
Accepted on: 03 May 2003.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

monopoly 发表于 2025-3-24 05:35:14

Submitted on: 14 October 2004.
Revised on: 07 February 2005.
Accepted on: 23 March 2005.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

报复 发表于 2025-3-24 09:18:57

http://reply.papertrans.cn/1/94/9339/9339-16.png

不安 发表于 2025-3-24 12:00:11

http://reply.papertrans.cn/1/94/9339/9339-17.png

ZEST 发表于 2025-3-24 18:19:57

Submitted on: 01 May 2017.
Revised on: 22 July 2017.
Accepted on: 01 August 2017.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

遗留之物 发表于 2025-3-24 21:46:44

Submitted on: 19 August 2011.
Revised on: 10 November 2011.
Accepted on: 29 December 2011.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY

impale 发表于 2025-3-25 01:09:02

Submitted on: 24 December 1999.
Revised on: 29 March 2000.
Accepted on: 26 May 2000.

___________________EUROPEAN NEUROPSYCHOPHARMACOLOGY
页: 1 [2] 3 4
查看完整版本: SCIE期刊EUROPEAN NEUROPSYCHOPHARMACOLOGY 2024/2025影响因子:6.196 (EUR NEUROPSYCHOPHARM) (0924-977X). (NEUROSCIENCES)(神经科学)Sci